A series of novel acyclic nucleoside analogues containing bis-(hydroxymethyl)phosphinic acid (BHPA) or tris(hydroxymethyl)phosphine oxide (THPO) coupled with DNA nucleobases or with 5-fluorouracil were prepared and their antiviral activity was studied against cytomegalovirus (CMV), varicella-zoster virus (VZV), parainfluenzavirus type 3, reovirus-type 1, sindbis, coxsackie B4, punta toro, vesicular stomatitis and respiratory syncytial virus, herpes simplex virus-type 1 (KOS) and type 2 (G), vaccinia virus and herpes simplex virus-1 (TK -KOS ACVr). No specific antiviral effects were noted for any of test compounds against viruses evaluated, except thymine, cytosine and adenine derivatives of BHPA exerting borderline activity against respiratory syncytial virus at the 80 mg/ml concentration.
Analogues of nucleosides and nucleotides in which the sugar moiety has been replaced by acyclic side-chains are of interest due to their attractive pharmacological properties (De Clercq et al., 1986; Pauwels et al., 1988) . Several purine-and pyrimidine-linked aliphatic derivatives have been found to be effective antiviral (Freeman & Gardiner, 1996; De Clercq, 2004) and anticancer agents (Abdulkarim et al., 2003; Valerianova et al., 2001) . Among them, aciclovir (Wagstaff et al., 1994) [1a], ganciclovir (Smee et al., 1983) [1b] and penciclovir (Harnden et al., 1987) [1c] are the best known representatives of this class of compounds ( Figure 1) .
The antiherpetic activity of acyclic analogues of nucleosides and nucleotides is attributed to their effective in vivo conversion into the corresponding mono-and then triphosphates (Snoeck et al., 1999) , which are more potent inhibitors of herpes virus DNA polymerases than of cellular DNA polymerases (Elion, 1983) . Alternatively, incorporation of such units into the growing DNA chain results in termination of the nucleic acid synthesis and blocking of the viral replication (Kramata et al., 1998) .
The search for new, more active or more selective antiviral agents involves various base or alkyl side-chain modifications. Within this vein, we considered the use of tris-(hydroxymethyl)phosphine oxide (THPO) or bis-(hydroxymethyl)phosphinic acid (BHPA) as new scaffolds for the alkyl side-chain coupled to DNA nucleobases or to 5-fluorouracil. We have already reported on a general method for the synthesis of a thymine-coupled BHPA derivative, a surrogate of thymidine nucleoside, and the incorporation of such a unit into the oligonucleotide chain (Nawrot et al., 2003 . BHPA was also used as a structural motif mimicking polyphosphate moieties in the preparation of Ap n A analogues, which proved to be effective inhibitors of ADP-triggered blood platelet aggregation (Walkowiak et al., 2002) .
Here we present the synthesis of acyclic nucleoside analogues being THPO and BHPA moieties, (Mitsunobu, 1981) Synthesis of [7a]. The mixture of compound [5] (300 mg, 0.40 mmol), triphenylphosphine (220 mg, 0.84 mmol) and N-3-benzoylthymine (112 mg, 0.48 mmol) was dried overnight in vacuum and then dissolved in anhydrous tetrahydrofuran (THF). Diisopropyl azodicarboxylate (DIAD) (0.16 ml, 0.84 mmol) was added dropwise via syringe and the mixture, protected against the light, was stirred overnight under argon at room temperature (RT). The solvent was then removed under reduced pressure. The residue was separated by silica gel column chromatography. Elution with CHCl 3 gave a desired product [7a] (627 mg) contaminated with phosphine oxide (~20% Mitsunobu reaction Preparation of [7d] . The N-2-isobutyryl-O-6-diphenylcarbamoylguanine (336.3 mg, 0.80 mmol) was suspended in anhydrous THF and the mixture was refluxed for 20 min to achieve partial dissolving of the starting material. Compound [5] (500 mg, 0.67 mmol), triphenylphosphine (369 mg, 1.4 mmol) and DIAD (275 µl, 1.4 mmol) were added dropwise to the cooled (RT) suspension and the mixture was stirred at darkness for 48 h at RT. After completion of the reaction (TLC) the solution was evaporated in vacuum and the residue was subjected to chromatographic purification. (620 mg in 30 ml) was treated with 28% aqueous ammonium hydroxide (20 ml) at RT for 24 h. The reaction progress was monitored by TLC. Plates were developed in CHCl 3 /MeOH 95:5, v/v. After removal of solvent, the residue was co-evaporated with toluene (10 ml) and then with ethanol (10 ml). The product was separated by flash column chromatography on silica gel with a gradient of methanol in chloroform (0-1%) to give pure (10 ml). The progress of the reaction was monitored by TLC (CHCl 3 /MeOH, 9:1). The reaction was terminated by addition of pyridine (0.4 ml) and the solvent was removed under reduced pressure. The residue was dissolved in water (30 ml) and washed with CHCl 3 (30 ml). The aqueous layer was concentrated under reduced pressure and the product was isolated by means of preparative TLC on a silica gel with an isopropanol:aqueous ammonium hydroxide:water (7:1:1) mixture to give [ 
Materials and methods

Chemistry
Typical procedure for the synthesis of [7a,c,e] and [12a,c,e], Mitsunobu reaction
Synthesis of [5]
4,4′-Dimethoxytriphenylmethyl chloride (6.8 g, 20 mmol) was added to the solution of [4] (1.4 g, 10 mmol) in anhydrous pyridine (150 ml). The mixture was stirred at ambient temperature for 20 h and then the solvent was removed under reduced pressure. The residue was poured onto silica gel column and eluted with CHCl 3 containing 0-2% of methanol. Desired product [5] was obtained with 50% yield (3.7 g, 5 mmol).
[ 
Preparation of [10]
Compound [10] was obtained as described in our previous work .
Virology
The antiviral assays were based on inhibition of virusinduced cytopathic effect in HEL fibroblasts, HeLa and Vero cell cultures, following the previously established procedures (De Clercq et al., 1980 .
Results and discussion
Chemistry
Coupling of nucleobases with a tris-(hydroxymethyl)phosphine oxide residue
Two OH functions of tris-(hydroxymethyl)phosphine oxide [4] were selectively protected with 4,4′-dimethoxytrityl (DMT) groups by the reaction with 2 equivalents of DMTCl (Figure 2) . The third OH group was activated in the presence of 4-N,N-dimethylaminopyridine (DMAP) with ptoluenesulphonyl chloride resulting in formation of [6].
Compound [5] was used as a substrate for a Mitsunobu reaction (Mitsunobu, 1981) Removal of the DMT groups was achieved under treatment of [8] with a methanolic solution of pTsOH. The progress of the reaction was monitored by TLC. Excess pTsOH was scavenged by pyridine added to the reaction mixture. After removal of the solvents, the reaction mixture was dissolved in water. Dimethoxytrityl alcohol was removed by extraction with chloroform and the residue was concentrated to dryness. Reaction products were isolated by means of TLC on preparative silica gel plates developed with an isopropanol/water/28% aqueous ammonia, 7:1:1, solvent mixture. Pure compounds [2] were eluted from the plates with the same solvent system and lyophilized as white powders. The yields of conversion of 
Coupling of nucleobases with a bis-(hydroxymethyl)phosphinic acid residue
Selective DMT-protection of one OH group and subsequent tosylation of the second OH group of bis-(hydroxymethyl)phosphinic acid methyl ester C-6 of the cytosine residue were assigned by 1 J H-C correlations in the HMQC spectrum.
3 J H-C correlation between the protons at C-1′ and C-2 and C-6 in the HMBC spectrum confirmed N-1 substitution ( Figure 5 Rather poor antiviral activity of test compounds indicates that acyclic nucleosides based upon replacement of the sugar moiety of antiviral nucleosides with bis-(hydroxymethyl)phosphinic acid or tris-(hydroxymethyl)phosphine oxide scaffolds may not undergo stepwise phosphorylation or do not inhibit enzymes responsible for viral replication.
